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Abschätzung der humanmedizinischen Bedeutung der 
Zoonose Tollwut in Deutschland – Analyse der verfügbaren 
Daten und Desiderate
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In order to assess the human medical significance of the rabies zoonosis in Ger-
many, the data of the relevant surveillance and of the registration systems as well 
as prescriptions submitted to the statutory health insurance (SHI) were assessed. 
In all, 2441 of the 81 280 total examinations for rabies conducted on animals 
were performed subsequent to contact with humans. In this context 54% of 
exposures were attributed to wild animals and 46%, to domestic animals. In 2006 
and 2002 there were still 0.42 and 0.34 veterinary medical analyses per 100 000 
inhabitants, respectively, subsequent to human contact. After the proclamation 
that Germany was free of terrestrial rabies, these indices dropped to 0.2 in 2009 
and 2010. During the survey period, 21 200 doses of rabies vaccine were issued 
annually for SHI prescriptions on average; they would have been adequate for 
approximately 2230 complete courses of rabies pre-exposure prophylaxis or 4340 
complete post-exposure treatments. For which of these two principal indications 
the vaccines were actually used cannot be determined from the SHI prescriptions. 
Taken together, the officially available data from rabies surveillance or registration 
systems even in combination with a nearly complete record of SHI prescription 
numbers did not allow an even nearly adequate reconstruction of the human 
medical significance of the rabies zoonosis in Germany. If one desired to achieve 
this, one would have to use, for example, an approach that is known from other 
European countries such as France, Finland, or the Netherlands.
Keywords: surveillance, rabies diagnosis, exposures to rabies, rabies prophylaxis, 
statutory health insurance
Um die humanmedizinische Bedeutung der Zoonose Tollwut in Deutschland 
abzuschätzen, wurden für die Jahre 2006–2010 Daten der einschlägigen „Surveil-
lance“ und des Meldewesens sowie die in der gesetzlichen Krankenversicherung 
eingelösten Rezepte ausgewertet. 2441 der insgesamt 81 280 an Tieren durch-
geführten Untersuchungen auf eine Rabiesinfektion gingen Personenkontakte 
voraus, wobei 54 % der Expositionen auf Wild- und 46 % auf Haustiere zurück-
zuführen waren. Entfielen in den Jahren 2006 und 2002 noch 0,42 und 0,34 
veterinärmedizinische Analysen nach Personenkontakt auf 100 000 Einwohner, so 
reduzierten sich diese Kennzahlen nach der Proklamation Deutschlands als frei 
von terrestrischer Tollwut auf jeweils 0,2 in 2009 bzw. 2010. Im Erhebungszeit-
raum wurden jährlich durchschnittlich 21 200 Dosen Tollwutimpfstoff auf „Kassen-
rezept“ bezogen, die ausgereicht hätten, um etwa 2230 vollständige Tollwut-Prä- 
oder 4340 komplette Post-Expositions-Prophylaxen vorzunehmen. Für welche die-
ser beiden prinzipiellen Indikationen die Vakzinen faktisch verwandt wurden, war 
den eingelösten GKV-Verordnungen ebenso wenig zu entnehmen, wie beispiels-
Zusammenfassung
Berliner und Münchener Tierärztliche Wochenschrift 125, Heft 5/6 (2012), Seiten 222–222 223
Introduction
The rabies virus and rabies-like viruses are typically 
transmitted to humans by bites of infected animals. They 
cause an encephalitic or paralytic disease that nearly 
always has a lethal course (World Health Organisation, 
2005; Bleck and Rupprecht, 2009). In many European 
countries it has been possible to successively eliminate 
rabies in the past 25 years by orally immunising foxes, 
and thus the Federal Republic of Germany – follow-
ing many of the neighbouring countries – was able to 
declare that it is free from classical (terrestrial) rabies 
in accordance with the criteria of the World Organisa-
tion for Animal Health in September 2008 (Cliquet and 
Aubert, 2004; Anonymous, 2008; World Organisation of 
Animal Health, 2008; Müller et al., 2012).
The official status of freedom from rabies initially mis-
leads one to describe the current human medical signifi-
cance of the rabies zoonosis in Germany as practically no 
longer existent. However, a more detailed consideration 
of the situation shows that such a conclusion is inappro-
priate because: (1) even in officially rabies-free Germany 
bat lyssa viruses are still endemic (van der Poel et al., 
2006; Müller et al., 2007; Deleré et al., 2011); (2) despite 
strict statutory regulations illegal import of domestic 
animals infected with rabies from endemic regions still 
occurs sporadically (Johnson et al., 2011); (3) German 
citizens are furthermore potentially exposed to rabies 
since, in accordance with conservative estimates, at least 
one out of eight of them travelled to rabies endemic 
areas in 2010 (Statistisches Bundesamt, 2011).
The following presentation attempts to assess the 
human medical significance of the rabies zoonosis in 
Germany based on available, representative data and 
to demonstrate existing desiderata in this context. The 
interval from 2006–2010 was selected as the survey 
period in order to be able to compare the last two years 
of national rabies endemism with the first two after 
proclamation of freedom from rabies. The focus of atten-
tion was particularly on the determination of exposure-
relevant human contacts and the number of rabies vac-
cinations performed – both of which are considered to 
be important indirect markers for the (national) human 
medical significance of the rabies zoonosis (Rimhanen-
Finne et al, 2009).
Material and Methods
The investigations performed in the years 2006–2010 
on domestic and wild animals in total and after previ-
ous human contacts in accordance with the Ordinance 
for Protection against Rabies (Verordnung zum Schutz 
gegen die Tollwut; Anonymous, 2010) were centrally 
recorded by the Friedrich-Loeffler-Institut.
In rabies surveillance, the direct immunofluorescence 
test (dIFT) was used as the analytical method of choice. 
Subsequent to previous human contact, the clarifica-
tion of initial dIFT negative or questionable results was 
possible by means of the Rabies Tissue Culture Infec-
tion Test with three serial passages (Dean et al., 1996; 
Webster and Casey, 1996; World Health Organisation, 
2005; World Organisation for Animal Health, 2008; Roß 
et al., 2009).
The nationwide registered rabies cases and exposures 
in the field of human medicine were recorded by the 
Robert-Koch-Institut. According to Sections 6 and 7 
of the Infection Protection Act (Infektionsschutzgesetz, 
IfSG; Anonymous, 2011a), the following are all equally 
subject to compulsory notification: (1) the traumatic 
injury of a human being by an animal that is infected 
with rabies, suspected of having rabies, or suspected of 
being contaminated; (2) contact with such an animal or 
animal cadaver; (3) the suspicion of disease for a person 
and his or her death due to the zoonosis.
The investigation of the nationwide rabies vaccine 
doses sold in the years 2006–2010 was conducted by 
the information service provider INSIGHT Health 
(Waldems-Esch and Berlin). In this context, the prescrip-
tions invoiced by the pharmacy computer centres in 
the scope of statutory health insurance (SHI) served as 
the data source. The data recorded by INSIGHT Health 
attained 99.8% coverage (http://www.insight-health.de. 
Last accessed: 15 February 2012).
Results
The number of domestic and wild animals examined 
in the framework of rabies surveillance in the years 
2006–2010 is summarised in Table 1.
During this five year period, a total of 81 280 animals 
underwent veterinary medical examinations for the pres-
ence of rabies infection by means of dIFT. The rabies sur-
veillance, which performed 96% of the analyses on the 
indigenous wild animal population, particularly focused 
on the target species fox.
In 2441 (3%) of all the tested animals there was 
prior human contact. In this context, wild animals were 
involved in 54% of exposures and domestic animals, in 
46% of them. Foxes dominated the spectrum of neces-
sary veterinary medical examination subsequent to wild 
weise der Ort einer erlittenen Exposition (Inland bzw. Tollwutendemiegebiet) 
oder Angaben darüber, ob die Impfserie abgeschlossen werden konnte oder aber 
unvollständig blieb. Insgesamt erlaubten so die aus der Tollwut-„Surveillance“ 
sowie dem -Meldewesen offiziell verfügbaren Daten selbst in Kombination mit 
einer fast vollständigen Erfassung von „GKV-Verordnungszahlen“ keine auch nur 
annähernd adäquate Rekonstruktion der humanmedizinischen Bedeutung der 
Zoonose Tollwut in Deutschland. Wollte man diese erreichen, so müsste man sich 
beispielsweise eines Vorgehens bedienen, das aus anderen europäischen Ländern 
wie Frankreich, Finnland oder den Niederlanden bekannt ist.
Schlüsselwörter: Surveillance, Rabies-Diagnostik, Rabies-Expositionen, Rabies-
Prophylaxe, gesetzliche Krankenversicherung
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animal contact with 59%, whereas cats and dogs made 
up 47% and 20%, respectively, of the analyses performed 
after domestic animal exposure.
A comparison of the numbers of veterinary medical 
examinations based on human contact in the years 2006 
and 2007 with those registered after Germany’s procla-
mation of freedom of terrestrial rabies in the years 2009 
and 2010, revealed a decline of 53 (wild animals) and 
37 (domestic animal) percentage points, respectively. 
Table 1: Examinations performed on domestic and wild animals in 
accordance with the Ordinance for Protection against Rabies (Verordnung 
zum Schutz gegen die Tollwut; Anonymous, 2010) in the years 2006–2010 
total examinations and examinations conducted subsequent to prior human 
contact
Year Type of animal Total exami-
nations (N)
Examinations sub-
sequent to human 
contact (N)
Examinations subsequent 
to human contact/100 000 
inhabitants1
2006 Domestic animals 0.36
   Dogs 124 56
   Cats 429 164
   Other 279 78
Wild animals 0.41
   Foxes 14 453 201
   Raccoon dogs 402 24
   Bats 77 21
   Other 1086 90
2007 Domestic animals 0.32
   Dogs 85 33
   Cats 330 158
   Other 288 72
Wild animals 0.43
   Foxes 14 848 212
   Raccoon dogs 248 40
   Bats 100 26
   Other 1446 79
2008 Domestic animals 0.27
   Dogs 83 46
   Cats 211 111
   Other 288 62
Wild animals 0.36
   Foxes 12 561 162
   Raccoon dogs 203 38
   Bats 76 24
   Other 1246 68
2009 Domestic animals 0.21
   Dogs 78 43
   Cats 188 -
   Other 200 127
Wild animals 0.21
   Foxes 15 641 103
   Raccoon dogs 148 17
   Bats 66 12
   Other 1413 38
2010 Domestic animals 0.222
   Dogs 118 47
   Cats 187 104
   Other 248 30
Wild animals 0.192
   Foxes 13 012 97
   Raccoon dogs 149 20
   Bats 86 20
   Other 883 18
∑ - 81 280 2441 -
1 The respective population level was determined using information from the Federal Statistical Office (http://
www.destatis.de/jetspeed/portal/cms/Sites/destatis/Internet/DE/Navigation/Statistiken/Bevoelkerung/ 
Bevoelkerungsstand/Bevoelkerungsstand.psml. Last accessed: 15 February 2012).
2 Since no official figure for the total population for 2010 was available, the value from the previous year was used 
for the calculation.
This tribute to freedom of terrestrial rabies also naturally 
manifested itself in the extrapolation to the popula-
tion as a whole. In 2006 and 2007 there were still 0.42 
and 0.34 veterinary medical examinations per 100  000 
inhabitants subsequent to prior human contact, but in 
the years 2009 and 2010 these indices dropped to 0.2, 
respectively.
According to Sections 6 and 7 IfSG, only one rabies 
notification was reported in the years 2006–2010. It 
concerned a man, who was 55 years old at 
that time and was bitten by a stray dog in 
Morocco in 2007. He indeed attempted to 
obtain medical assistance there, but did not 
receive any rabies post-exposure treatment. 
After his return to Germany, initially unspe-
cific symptoms developed into hydrophobia, 
which could ultimately be ascribed to a rabies 
infection by means of medical laboratory 
tests. Despite an experimental treatment by a 
modified version of the Milwaukee Protocol 
(Willoughby et al., 2005; Anonymous, 2009), 
the patient died 31 days after onset of symp-
toms (Schmiedel et al., 2007).
In the years 2006–2010, 108  536 doses of 
rabies vaccine were prescribed to patients 
in the German SHI system (Tab. 2). This 
corresponded to an annual average of 
approximately 21  700 doses. 56% of all 
prescriptions were made by general practition-
ers. 17% were issued by internal specialists, 
whereas 9% each were accounted for by phy-
sicians working in hospitals and institutes or 
paediatricians. The remaining 9537 prescrip-
tions were made by surgeons (6%) and phy-
sicians with other or unknown specialities, 
(3%), respectively.
Discussion
In the above, an attempt was made to assess 
the human medical significance of the rabies 
zoonosis in Germany for the years 2006–2010 
based on available representative data. In 
the process the focus was placed on the 
determination of exposure-relevant human 
contacts and the number of performed rabies 
vaccinations.
The data recorded in the scope of the vet-
erinary medical surveillance in accordance 
with the Rabies Ordinance (Anonymous, 
2010) verified that approximately 3% of all 
the examined animals had been previously 
responsible for the exposure of a person. 
However, it is conceivable that some of these 
animals had been shot and were examined 
without a real exposure-relevant incident 
simply because a hunter had touched the 
cadaver. Beyond this, the above-mentioned 
numbers concerned only those cases in 
which it had been possible to obtain the 
causative animal and subsequently examine 
it. Therefore, one must assume that the offi-
cially available data was indeed an underrep-
resentation of the actual autochthonous inci-
dence of exposure. The population-oriented 
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indices determined in our survey (0.77 [2006] to 0.41 
[2010]) therefore could not be easily compared with cor-
responding information on exposure-relevant incidents 
in other countries – for example, with existing data from 
Finland (0.23/100  000, Rimhanen-Finne et al., 2009), 
France (16/100 000, Gautret et al., 2008), or the United 
States of America (27/100  000, Blanton et al., 2005). 
Despite this principal restriction, foxes (59% of wild 
animal contacts) as well as cats and dogs (47% and 20%, 
respectively, of the domestic animal contacts) had been 
shown to be particularly responsible for the potentially 
significant incidents of exposure to rabies in human 
medicine. The fact that the number of examinations 
performed on wild and domestic animals subsequent 
to human contacts decreased by 53 and 37 percentage 
points in the years 2009/2010 compared to 2006/2007 
might primarily be due the meanwhile altered rabies 
epidemiology in Germany. This fact was evidently rec-
ognised in veterinary medicine much earlier than in 
its human medical counterpart and consequently also 
resulted in earlier corresponding changes in the “order-
ing behaviour” there.
According to conservative estimates, every eighth Ger-
man citizen travelled in rabies endemic areas in 2010 
(Statistisches Bundesamt, 2011). How many of these 
individuals actually underwent pre-exposure vaccina-
tions against rabies infection is unknown. The little data 
available in this respect, however, suggests that seri-
ous flaws might exist. Travel health advisors in one of 
Germany’s largest public health offices, for instance, in 
2002–2004 only provided pre-exposure vaccination to 
7.0–11.2% of those persons desiring to visit a country 
where rabies is endemic (Heudorf et al, 2006). Reli-
able information on the exposure of German citizens to 
rabies outside of Germany is also lacking. An approxi-
mate perception of their extent can solely be conveyed 
by general statistical considerations. Since the exposure 
frequency elicited only by dogs in Africa and Asia can 
be estimated to be a minimum of 100/100 000 (Meslin, 
2005), at least 10  000 German citizens must have suf-
fered from rabies exposure that required a post-exposure 
prophylaxis during their holidays.
Germany does not have a general vaccination reg-
istry in human medicine and mandatory vaccination 
registration exists only in Saxony Anhalt. The means for 
vaccination surveillance stipulated in the IfSG are there-
fore unavoidably restricted to school entry examinations 
(section 34, para. 11). Furthermore, in section 20, para. 4, 
the Federal Ministry of Health is entitled to regulate 
the funding of vaccinations via the SHI companies by 
legal decree as well as to promote the transmission 
of anonymised data with regard to such vaccination 
campaigns (Anonymous, 2000; Oppermann et al., 2009; 
Anonymous, 2011a).
Our survey therefore had to search for sources able to 
give a reliable estimate on the administered rabies vac-
cine doses nationwide in the years 2006–2010 beyond the 
information available from the government. INSIGHT 
Heath provided us with the missing data. This is based 
on the number of prescriptions redeemed by the Ger-
man federal SHI. Approximately 90% of all Germans 
are insured by this type of medical service provision. 
Therefore, the data collected by INSIGHT Health repre-
sents a nearly complete registration of the SHI prescrip-
tions invoiced in the pharmacy computer centres (http://
www.insight-health.de. Last accessed: 15 February 2012; 
Table 2: Number of nationwide prescriptions of rabies vaccine 
in the years 2006–2010, as determined from the sum of the 
redeemed prescriptions in the SHI under consideration of the 
medical speciality of the prescribing physician
Year Medical speciality Prescriptions (N)
2006 General practitioners 11 544
Internists 3137





2007 General practitioners 14 625
Internists 4557





2008 General practitioners 12 938
Internists 4384





2009 General practitioners 9478
Internists 2736





2010 General practitioners 12 066
Internists 3904






gkvnet. Last accessed: 15 February 2012).
The 108 536 doses of rabies vaccine obtained with an 
SHI prescription in Germany in the years 2006–2010 
were issued by physicians of different specialisations. 
The observed distribution of disciplines may have cor-
responded to the spectrum of the respective first spe-
cialist contacts of the patients to a large extent. The 
decrease in number of sales in the year 2009 could very 
probably not be explained by Germany’s proclama-
tion of freedom from terrestrial rabies, but much more 
likely by the bottlenecks in the supply of rabies vaccine, 
which were observed at that time. They occurred for 
production-technical reasons and at the international 
level even resulted in a curtailment of the post-exposure 
prophylaxis according to the classical “Essen Scheme”, 
which had been adhered to for decades (Rupprecht et 
al., 2009). The 21 700 vaccine doses sold annually across 
Germany would have sufficed to have performed 7230 
complete courses of rabies pre-exposure prophylaxis or 
4340 complete post-exposure treatments. Based on the 
actual SHI sales figures, it was not possible to determine 
for which of these two principal indications the vaccine 
had actually been used. Nor did they provide any infor-
mation on whether, for example, an underlying exposure 
occurred in inland or on trips in rabies endemic areas or 
whether the respective vaccination cycle could be com-
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pleted. A certain improvement in this regard would have 
been expected from the generally welcomed extended 
and standardised documentation key in accordance with 
the Annex 2 of the so-called “Vaccination Guideline” 
(„Schutzimpfungs-Richtlinie“; Anonymous, 2011b). 
Unfortunately, however, this regulation is not applicable 
to rabies because it, on the one hand, does not include 
the post-exposure administration of sera or chemothera-
peutics and, on the other hand, travel vaccinations and 
an occupational hazard due to the zoonosis normally 
do not justify an entitlement for benefits from the SHI 
(Oppermann et al., 2009).
The representative data available from veterinary 
medical surveillance, from the official compulsory noti-
fication in human medicine, and from the analysis of 
redeemed SHI prescriptions do not currently allow an 
even semi-adequate reconstruction of the human medi-
cal significance of the rabies zoonosis in the Federal 
Republic of Germany. In order to obtain as complete a 
picture as possible, one would have to follow the exam-
ple of some of our European neighbours. France, for 
instance, has a blanket coverage network of specialised 
rabies treatment centres. They transmit all the collected 
information including the details of a possible initiated 
treatment to the National Reference Centre for Rabies. 
This, in turn, publishes an annually updated bulletin 
with all relevant information on the national epide-
miology and prophylaxis of rabies in humans (Institut 
Pasteur, 2011). In Finland there is not only the veteri-
nary medical surveillance data, which is also available 
in Germany. Additional information exists on the actual 
number of incurred human exposures since at least 
those contacts which require a rabies post-exposure 
prophylaxis must be compulsorily recorded in a registry 
especially set up for human medicine (Rimhanen-Finne 
et al., 2009). Finally, in the Netherlands, rabies vaccines 
and hyperimmunoglobulin preparations are only avail-
able from the National Vaccine Institute. Furthermore, 
their application is subject to a quality control to the 
extent that a team of experts of the Preparedness and 
Response Unit at the Centre of Infectious Disease Con-
trol critically checks the respective decentrally prepared 
prescriptions and corrects them if necessary (Beaujean 
et al., 2008).
On the one hand, if Germany was also to proceed 
according to the example of one of the three above-men-
tioned countries, essential data on the current human 
medical significance of the rabies zoonosis would be 
generated. On the other hand – and at least as impor-
tant – in this manner it would be possible to achieve 
a far-reaching standardisation in the determination of 
the indications for rabies post-exposure prophylaxis. 
Thus, substantial uncertainties, which exist even for 
experienced physicians in the field, might be eliminated 
(Schönfeld et al., 2003; Hossain et al., 2004; Ross et al., 
2006; Gautret et al., 2008, 2009; Pavli et al., 2011; Wijaya 
et al., 2011).
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